Macromolecules from mushrooms, venoms, microorganisms, and plants for diabetes treatment - Progress or setback?
Biochimie
; 2024 Jul 10.
Article
em En
| MEDLINE
| ID: mdl-38996998
ABSTRACT
Diabetes is a substantial public health issue, while its prevalence continues to rise worldwide, affecting millions of persons between the ages of 20 and 80, the development of new therapeutic classes improving glycemic control and consequently micro and macrovascular complications are needed. Today, diabetes treatment is daily for life, and should not be interrupted. However, insulin secretagogues medications, and exogenous self-administration of insulin provide efficient antidiabetic effects, but their misuse leads to hypoglycemic complications besides other risks, hence the need to look for other natural products not to use solely but in concert with others types of medications. In this review, we will highlight briefly the pathophysiology of diabetes and its complications, then we will report the main bioactive macromolecules derived from various sources of natural products providing anti-diabetic properties. However, further researches need to be carried out to face the limitations hampering the development of effective natural drugs for diabetes treatment.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Biochimie
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Marrocos